title: Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome.
abstract: OBJECTIVE
  To investigate the prognostic significance of endocan, compared with procalcitonin (PCT), C-reactive protein (CRP),white blood cells (WBC), neutrophils (N), and clinical severity scores in patients with ARDS.
  
  
  METHODS
  A total of 42 patients with ARDS were initially enrolled, and there were 20 nonsurvivors and 22 survivors based on hospital mortality. Plasma levels of biomarkers were measured and the acute physiology and chronic health evaluation II (APACHE II) was calculated on day 1 after the patient met the defining criteria of ARDS.
  
  
  RESULTS
  Endocan levels significantly correlated with the APACHE II score in the ARDS group (r = 0.676, P = 0.000, n = 42). Of 42 individuals with ARDS, 20 were dead, and endocan was significantly higher in nonsurvivors than in survivors (median (IQR) 5.01 (2.98-8.44) versus 3.01 (2.36-4.36) ng/mL, P = 0.017). According to the results of the ROC-curve analysis and COX proportional hazards models, endocan can predict mortality of ARDS independently with a hazard ratio of 1.374 (95% CI, 1.150-1.641) and an area of receiver operator characteristic curve (AUROC) of 0.715 (P = 0.017). Moreover, endocan can predict the multiple-organ dysfunction of ARDS.
  
  
  CONCLUSIONS
  Endocan is a promising biomarker to predict the disease severity and mortality in patients with ARDS.
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
authors.forename: Ling
authors.initials: L
authors.lastname: Tang
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
authors.forename: Daoxin
authors.identifier: 0000-0002-6012-6815
authors.initials: D
authors.lastname: Wang
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
authors.forename: Wang
authors.initials: W
authors.lastname: Deng
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
authors.forename: Changyi
authors.initials: C
authors.lastname: Li
authors.affiliation: Respiratory Department, Xinqiao Hospital, Chongqing 400037, China.
authors.forename: Qi
authors.initials: Q
authors.lastname: Li
authors.affiliation: Respiratory Department, First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
authors.forename: Shicong
authors.initials: S
authors.lastname: Huang
authors.affiliation: Respiratory Department, Tong Liang County People's Hospital, Chongqing 402560, China.
authors.forename: Chang
authors.initials: C
authors.lastname: Shu
mesh_terms: D018806:APACHE; D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000097:blood*; D011509:Proteoglycans / Q000097:blood*; D012128:Respiratory Distress Syndrome / Q000097:blood* / Q000473:pathology; D055815:Young Adult
chemical_list: D015415:Biomarkers; C101134:ESM1 protein, human; D009363:Neoplasm Proteins; D011509:Proteoglycans